BURLINGTON, Ontario, March 31, 2020 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce that RDT has completed its first shipment of QuickStrip™ nutraceutical products to Peter Pan Brands. The QuickStrip™ nutraceutical product line will be distributed by Peter Pan Brands and sold across Ontario in multiple retail locations.
RDT’s proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral, fast-dissolving drug delivery system that offers consumers an “anytime, anywhere” solution.“We are excited for QuickStrip™ to expand our reach within the Canadian market with Peter Pan Brands to provide consumers an alternative delivery system for vitamins and supplements which does not require swallowing; as with traditional pills or drinks,” said Jason Lewis, SVP business development. “QuickStrip™ can transform how consumers take their daily supplements and vitamins, offering a fast-acting and convenient format to fit into any lifestyle.”To further our commitment to our customers, RDT is continuing to operate while carefully considering the safety of our employees and customers. As the COVID-19 pandemic continues to evolve and have an impact across the country, RDT is placing the utmost priority in our effort to keep our customers and team members safe while minimizing the risk of any possible transmission in the communities where we live and work. RDT continues to monitor the situation closely and is prepared to respond quickly and appropriately to the rapidly changing nature of this pandemic.About Rapid Dose TherapeuticsRapid Dose Therapeutics Corp. is a publicly traded Canadian life sciences company that provides innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry, including nutraceutical, pharmaceutical and cannabis industries. Within the cannabis sector, RDT provides a turn-key business solution which enables RDT’s QuickStrip™ proprietary drug delivery technology to be licensed by select partners. RDT’s service-based annuity contracts drive recurring revenue which enables rapid expansion into emerging markets — generating value for consumers and shareholders. RDT is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs — including humans, animals and plants.For more information, visit: www.rapid-dose.comFor further inquiries please contact:Mark Upsdell
CEO
mupsdell@rapid-dose.com
(647) 200-4709Social Media
RapidDoseTherapeutics.linkedin
RapidDoseTherapeutics.twitter
RapidDoseTherapeutics.facebook
QuickStrip.instagram
Bay Street News